Barton J Dear1, Jessica J Hung1, Thomas M Truskett1, Keith P Johnston2. 1. McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA. 2. McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA. kpj@che.utexas.edu.
Abstract
PURPOSE: To explain the effects of cationic amino acids and other co-solutes on the viscosity, stability and protein-protein interactions (PPI) of highly concentrated (≥200 mg/ml) monoclonal antibody (mAb) solutions to advance subcutaneous injection. METHODS: The viscosities of ≥200 mg/ml mAb1 solutions with various co-solutes and pH were measured by capillary rheometry in some cases up to 70,000 s-1. The viscosities are analyzed in terms of dilute PPI characterized by diffusion interaction parameters (k D ) from dynamic light scattering (DLS). MAb stability was measured by turbidity and size exclusion chromatography (SEC) after 4 weeks of 40°C storage. RESULTS: Viscosity reductions were achieved by reducing the pH, or adding histidine, arginine, imidazole or camphorsulfonic acid, each of which contains a hydrophobic moiety. The addition of inorganic electrolytes or neutral osmolytes only weakly affected viscosity. Systems with reduced viscosities also tended to be Newtonian, while more viscous systems were shear thinning. CONCLUSIONS: Viscosity reduction down to 20 cP at 220 mg/ml mAb1 was achieved with co-solutes that are both charged and contain a hydrophobic interaction domain for sufficient binding to the protein surface. These reductions are related to the DLS diffusion interaction parameter, k D , only after normalization to remove the effect of charge screening. Shear rate profiles demonstrate that select co-solutes reduce protein network formation.
PURPOSE: To explain the effects of cationic amino acids and other co-solutes on the viscosity, stability and protein-protein interactions (PPI) of highly concentrated (≥200 mg/ml) monoclonal antibody (mAb) solutions to advance subcutaneous injection. METHODS: The viscosities of ≥200 mg/ml mAb1 solutions with various co-solutes and pH were measured by capillary rheometry in some cases up to 70,000 s-1. The viscosities are analyzed in terms of dilute PPI characterized by diffusion interaction parameters (k D ) from dynamic light scattering (DLS). MAb stability was measured by turbidity and size exclusion chromatography (SEC) after 4 weeks of 40°C storage. RESULTS: Viscosity reductions were achieved by reducing the pH, or adding histidine, arginine, imidazole or camphorsulfonic acid, each of which contains a hydrophobic moiety. The addition of inorganic electrolytes or neutral osmolytes only weakly affected viscosity. Systems with reduced viscosities also tended to be Newtonian, while more viscous systems were shear thinning. CONCLUSIONS: Viscosity reduction down to 20 cP at 220 mg/ml mAb1 was achieved with co-solutes that are both charged and contain a hydrophobic interaction domain for sufficient binding to the protein surface. These reductions are related to the DLS diffusion interaction parameter, k D , only after normalization to remove the effect of charge screening. Shear rate profiles demonstrate that select co-solutes reduce protein network formation.
Authors: V Burckbuchler; G Mekhloufi; A Paillard Giteau; J L Grossiord; S Huille; F Agnely Journal: Eur J Pharm Biopharm Date: 2010-08-16 Impact factor: 5.571
Authors: P Douglas Godfrin; Isidro E Zarraga; Jonathan Zarzar; Lionel Porcar; Peter Falus; Norman J Wagner; Yun Liu Journal: J Phys Chem B Date: 2016-01-07 Impact factor: 2.991
Authors: Brian D Connolly; Chris Petry; Sandeep Yadav; Barthélemy Demeule; Natalie Ciaccio; Jamie M R Moore; Steven J Shire; Yatin R Gokarn Journal: Biophys J Date: 2012-07-03 Impact factor: 4.033
Authors: Jessica J Hung; Barton J Dear; Aileen K Dinin; Ameya U Borwankar; Sumarth K Mehta; Thomas T Truskett; Keith P Johnston Journal: Pharm Res Date: 2018-04-30 Impact factor: 4.200